Samsung Biologics in $411-M Mfg Pact with Pfizer; Updates Timeline for New Biomanufacturing Facility
By
Samsung Biologics, a CDMO of biologics, has formed a strategic partnership for the long-term commercial manufacturing of Pfizer’s multi-product biosimilars portfolio and also provided an update on a new biomanufacturing…